dc.contributor.author | Sorriento, Daniela | |
dc.contributor.author | Trimarco, Bruno | |
dc.contributor.author | Iaccarino, Guido | |
dc.date.accessioned | 2013-04-02T15:10:52Z | |
dc.date.available | 2013-04-02T15:10:52Z | |
dc.date.issued | 2011 | |
dc.identifier.citation | Sorriento D, Trimarco B, Iaccarino G. Adrenergic mechanism in the control of endothelial function. Translational Medicine @ UniSa 2011;1(1):213-228 | en_US |
dc.identifier.issn | 2239-9747 | en_US |
dc.identifier.uri | http://hdl.handle.net/10556/514 | |
dc.description.abstract | There is considerable evidence that many disease are associated with endothelial dysfunction and reduced nitric oxide production such as hypertension, obesity, dyslipidemias, diabetes, heart failure, atherosclerosis. Notably these conditions are also characterized by alteration in the adrenergic tone. Whether these two mechanisms are just epiphenomenal each other or there is a functional link, it is still to be established. A starting ground to establish this issue is that vascular endothelium plays an important role in the function of cardiovascular system and that adrenergic receptors on endothelial cells contribute to the regulation of vasomotor tone. The aim of this excerpt is to review current knowledge on the physiology of endothelial adrenergic receptors to contribute to the basis for newer and better approaches to endothelial dysfunction in the setup of cardiovascular conditions. | en_US |
dc.language.iso | en | en_US |
dc.source | UniSa. Sistema Bibliotecario di Ateneo | en_US |
dc.title | Adrenergic mechanism in the control of endothelial function | en_US |
dc.type | Article | en_US |